MedPath

Efficacy of a reduced-sodium salt substitute on blood pressure in hypertensive patients

Phase 2
Recruiting
Conditions
Patients older than 40 years with a diagnosis of Essential or Primary Hypertension.
Hypertension
low sodium
Registration Number
TCTR20240722001
Lead Sponsor
/A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
64
Inclusion Criteria

Patients older than 40 years with a diagnosis of Essential or Primary Hypertension.

Exclusion Criteria

Have salt-losing nephropathy.
Received drugs that affect sodium in the body, such as thiazide drugs, furosemide, etc.
Patients with swelling due to high ECF causing low sodium. such as patients with heart failure, liver failure
Patients with chronic kidney disease stage 3b (CKD stage3b) and above or GFR<45mL/min/1.73 squaremeter
Patients with syndrome of inappropriate ADH secretion (SIADH).
Participants who ate out more than once per week.
Participants with food allergies to soybeans. Wheat and oysters
Those who do not agree to act according to the doctor's advice in accordance with the research protocol. or have a physical mental disorder that affects the follow-up of the research study
Patients diagnosed with Hypertensive urgency or Hypertensive emergency.
Participants who cannot read Thai and cannot write letters.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood Pressure 1 week and 8 week Sphygmomanometer
Secondary Outcome Measures
NameTimeMethod
24-h urine Na excretion 1 week and 8 week Laboratory Examination,food record 1 week and 8 week recall, record
© Copyright 2025. All Rights Reserved by MedPath